2Regolisti G, Maggiore U, Cademartiri C, et al. Cerebral perfusion during intermittent hemodialysis in patients with acute kidney injury and advanced liver cirrhosis [ J ]. J Nephrol, 2013,26 (4) : 771-777. 被引量：1
3Hafner V, Czoek D, Burhenne J, et al. Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafihration[ J]. Antimicrob Agents Chemother, 2010,54(6) :2596-2602. 被引量：1
4Merouani A, Keehaou W, Litalien C, et al. Impact of blood volume monitoring on fluid removal during intermittent hemodialysis of critically ill children with acute kidney injury [ J ]. Nephrol Dial Transplant,2011,26(10) :3315-3319. 被引量：1
5Quader MA, Kumar D, Shah KB, et al. Safety analysis of intermittent hemodialysis in patients with continuous flow left ventricular assist devices[J]. Hemodial Int,2014,18( 1 ) :205-209. 被引量：1
6Golestaneh L, Richter B, Amato-Hayes M. Logistics of Renal Replacement Therapy: Relevant Issues for Critical Care Nurses [J]. Am J Crit Care,2012,21(2) :126-130. 被引量：1
7Tolwani A. Continuous renal-replacement therapy for acute kidney injury[J]. N Engl J Med,2012,367(26) :2505-2514. 被引量：1
8Soiag Yanfang, Zhang Hong. The effect of Valsartan mainte- nance hemodialysis patients with cardiac function and struc- ture[J]. Progress in Modem Biomedicine, 2012, 12(23): 4485. 被引量：1
10Feng Jing, Zhang Xinkai. Comparison of the Efficacy of highfluxhemodialysis and hemodiafiltration in patients with chronic renal failure [J ]. Progress in Modem Biomedicine, 2011, 11(22): 4314. 被引量：1
